2022
DOI: 10.1016/j.mtbio.2022.100468
|View full text |Cite
|
Sign up to set email alerts
|

Design of biopolymer-based hemostatic material: Starting from molecular structures and forms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 189 publications
0
12
0
Order By: Relevance
“…The hemostats used to fill the wound should be of appropriate mechanical strength to prevent deformation due to external stresses from the surrounding tissues Figures S8 and S9 show that GPZ had higher deformation resistance than Gel, GP, and GZ.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The hemostats used to fill the wound should be of appropriate mechanical strength to prevent deformation due to external stresses from the surrounding tissues Figures S8 and S9 show that GPZ had higher deformation resistance than Gel, GP, and GZ.…”
Section: Resultsmentioning
confidence: 99%
“…The hemostats used to fill the wound should be of appropriate mechanical strength to prevent deformation due to external stresses from the surrounding tissues. 37 Figures S8 and S9 show that GPZ had higher deformation resistance than Gel, GP, and GZ. Absorbing water after compression of the sponge, the GPZ sponge can quickly return to its original shape, as shown in Figure 2C.…”
Section: Physical Properties Of the Gpz Spongementioning
confidence: 99%
“…[ 11 ] Among them, powdered hemostats exhibit outstanding features, including portability, ready‐to‐use for non‐trained persons, the ability to be directly sprayed over a large defect area irrespective of the exact bleeding site, and are suitable for irregular and non‐compressible bleeding wounds. [ 3a,12 ] Upon applying to the wound bed, the porous structure of hemostatic powders can rapidly absorb blood and concentrate coagulation factors to facilitate blood clotting. However, existing commercially available hemostatic powders such as zeolite‐based QuickClot, chitosan‐based Celox, and starch‐based Arista usually display relatively weak mechanical strength, lack of enough tissue adhesion, and/or low biocompatibility.…”
Section: Introductionmentioning
confidence: 99%
“…Various hemostatic agents (e.g., powder and hydrogels) have been widely designed for the wound hemorrhage. In some cases, bleeding after tissue puncture with syringe needles could cause psychological fear in patients, especially for children. Further, it increases the risk of local or systemic complications (e.g., subcutaneous bruises, swelling, nerve damage, and uncontrolled bleeding) in patients suffering from hemophilia, Von Willebrand disease, vitamin K deficiency, rat poisoning, warfarin poisoning, and disseminated intravascular coagulation. , Recently, a self-sealing hemostatic needle coated with catechol-conjugated chitosan has been reported for antibleeding after tissue puncture via solid-to-gel phase transition of catechol-functionalized chitosan. , However, the preparation process of hemostatic needles either involved complex modification of polymers or an oxidative preincubation process of 3 days to achieve hemostatic functions. Sodium alginate and CaCl 2 have been also used to decorate hypodermic needles, which also exhibit hemostasis during tissue puncture. , Nevertheless, the coating detached from the needle surface only serves as a physical barrier to prevent bleeding without affording antibacterial activity, while infection occurs more often at punctured sites and obstructs the healing of the punctured tissue.…”
Section: Introductionmentioning
confidence: 99%
“…Further, it increases the risk of local or systemic complications (e.g., subcutaneous bruises, swelling, nerve damage, and uncontrolled bleeding) in patients suffering from hemophilia, Von Willebrand disease, vitamin K deficiency, rat poisoning, warfarin poisoning, and disseminated intravascular coagulation. 6,7 Recently, a self-sealing hemostatic needle coated with catechol-conjugated chitosan has been reported for antibleeding after tissue puncture via solid-to-gel phase transition of catechol-functionalized chitosan. 8,9 However, the preparation process of hemostatic needles either involved complex modification of polymers or an oxidative preincubation process of 3 days to achieve hemostatic functions.…”
Section: Introductionmentioning
confidence: 99%